1. Home
  2. TREE vs DCTH Comparison

TREE vs DCTH Comparison

Compare TREE & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingTree Inc.

TREE

LendingTree Inc.

N/A

Current Price

$30.79

Market Cap

533.1M

Sector

Finance

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$16.76

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TREE
DCTH
Founded
1996
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.1M
578.4M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
TREE
DCTH
Price
$30.79
$16.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$71.25
$22.00
AVG Volume (30 Days)
458.5K
685.2K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
443.31
107.53
EPS
1.90
0.04
Revenue
$1,117,324,000.00
N/A
Revenue This Year
$19.03
$24.54
Revenue Next Year
$7.07
$33.15
P/E Ratio
$16.43
$428.75
Revenue Growth
24.12
N/A
52 Week Low
$29.77
$8.12
52 Week High
$77.35
$17.42

Technical Indicators

Market Signals
Indicator
TREE
DCTH
Relative Strength Index (RSI) 31.74 66.18
Support Level $29.77 $10.16
Resistance Level $39.74 $17.42
Average True Range (ATR) 1.30 0.82
MACD -0.01 0.18
Stochastic Oscillator 1.90 86.98

Price Performance

Historical Comparison
TREE
DCTH

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: